Does CARVEDILOL Cause Product distribution issue? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product distribution issue have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 0.0% of all adverse event reports for CARVEDILOL.
6
Reports of Product distribution issue with CARVEDILOL
0.0%
of all CARVEDILOL reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product distribution issue From CARVEDILOL?
Of the 6 reports, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CARVEDILOL Cause?
Hypotension (1,822)
Dyspnoea (1,143)
Dizziness (1,138)
Drug ineffective (1,102)
Fatigue (1,020)
Completed suicide (1,019)
Bradycardia (861)
Toxicity to various agents (690)
Cardiac failure (636)
Asthenia (562)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which CARVEDILOL Alternatives Have Lower Product distribution issue Risk?
CARVEDILOL vs CASIMERSEN
CARVEDILOL vs CASIRIVIMAB
CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB
CARVEDILOL vs CASPOFUNGIN
CARVEDILOL vs CATEQUENTINIB